Renal Association Clinical Practice Guideline on planning, initiating and withdrawal of renal replacement therapy.
نویسندگان
چکیده
This guideline provides recommendations on best practice in the planning, initiating and withdrawal of renal replacement therapy. The guideline links with many of the objectives relating to renal replacement therapy described within the National Service Framework for Renal Services Part 1 [1]. This NSF document highlighted the need for renal units to deliver individualised patient education to allow patients to make an informed choice of treatment modality, timely preparation for renal replacement therapy and empowerment of the patient from the start to the end of their treatment pathway. In the preparation of this guideline the authors performed a systematic search of the literature on planning and initiating of renal replacement therapy and end of life care which was published in English up to February 2009. The evidence for these recommendations has been assessed using the modified GRADE system. The modified GRADE system defines both the strength of the recommendations of the guideline authors and the level of evidence upon which each of the recommendations is based. This grading system classifies expert recommendations as ‘strong’ (Grade 1) or ‘weak’ (Grade 2) based upon the balance between the benefits and risks, burden and cost. The quality or level of evidence is designated as high (Grade A), moderate (Grade B), low (Grade C) or very low (D) depending on factors such as study design, directness of evidence
منابع مشابه
NDT Perspectives A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapy
This paper provides an endorsement of the KDIGO guideline on acute kidney injury; more specifically, on the part that concerns renal replacement therapy. New evidence that has emerged since the publication of the KDIGO guideline was taken into account, and the guideline is commented on from a European perspective. Advice is given on when to start and stop renal replacement therapy in acute kidn...
متن کاملبررسی ارتباط بین بیماری کلیه پلی کیستیک و دیابت پس از پیوند کلیه
Background: Autosomal-dominant polycystic kidney disease (ADPKD), a common hereditary disease, is characterized by the progressive development and enlargement of multiple cysts in both kidneys, and typically resulting in end stage renal disease (ESRD) by the fifth decade of life. Post-transplant diabetes mellitus (PTDM), a common complication after transplantation with an incidence rate of 2.5-...
متن کاملUK Renal Registry 16th annual report: chapter 11 blood pressure profile of prevalent patients receiving renal replacement therapy in 2012: national and centre-specific analyses.
INTRODUCTION There continues to be uncertainty in the literature about which blood pressure (BP) recordings in which time period associate best with long-term patient outcomes and therefore optimal target ranges. METHODS Patients receiving renal replacement therapy (RRT) on 31st December 2012 with a BP reading in either the fourth or third quarter of 2012 were included. Summary statistics wer...
متن کاملRenal Association Clinical Practice Guideline on vascular access for haemodialysis.
Vascular access remains a key component of haemodialysis. The ideal vascular access should provide safe and effective therapy by enabling the removal and return of blood via an extracorporeal circuit. Vascular access should be easy to use, reliable and have minimal risk to the individual receiving haemodialysis. However, the provision of good quality access, whilst it is a fundamental aspect of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephron. Clinical practice
دوره 118 Suppl 1 شماره
صفحات -
تاریخ انتشار 2011